Abstract
Etoposide (VP16), an anti-neoplastic agent, exhibits low and variable bioavailability. We have developed and validated a rapid, sensitive, and accurate LC–UV method for the determination of VP16 in vitro and in rat plasma after oral administration. The method was then used to investigate the absorption characteristics of VP16 with an in vitro diffusion chamber system across isolated rat intestinal membranes as a model. Borneol and eugenol were used to enhance the intestinal absorption of VP16. We also examined the effect of borneol and eugenol on the intestinal absorption of VP16 in vivo. The results showed that the plasma concentration of VP16 was significantly increased; relative bioavailability was 2.2-fold and 2.9-fold enhancement in the presence of borneol and eugenol, respectively, compared to VP16 administered alone.
Similar content being viewed by others
References
Baldwin EL, Osheroff N (2005) Curr Med Chem Anticancer Agents 5:363–372. doi:10.2174/1568011054222364
Montecucco A, Biamonti G (2007) Cancer Lett 252:9–18. doi:10.1016/j.canlet.2006.11.005
Meresse P, Dechaux E, Monneret C, Bertounesque E (2004) Curr Med Chem 11:2443–2466
Toffoli G, Corona G, Basso B, Boiocchi M (2004) Clin Pharmacokinet 43:441–466
Wang YR, He Y (2007) Zhongguo ShenghuaYaowu Zazhi 28:66–69
Bollmann A, Lewis K, Epstein SS (2007) Appl Environ Microbiol 73:6386–6390. doi:10.1128/AEM.01309-07
Yang H, Finaly R, Teitelbaum DH (2003) Crit Care Med 31:1118–1125
Li GF, Chen JH, Yang J, Guo D, Ren F, Wang CX, Hou LB (2004) Diyijunyi Daxue Xuebao 24:11–14
Nishimura T, Kato Y, Amano N, Ono M, Kubo Y, Kimura Y, Fujita H, Tsuji A (2008) Pharm Res 25:2467–2476. doi:10.1007/s11095-008-9658-4
Cárcel-Trullols J, Torres-Molina F, Araico A, Saadeddin A, Peris JE (2004) Cancer Chemother Pharmacol 54:153–160. doi:10.1007/s00280-004-0784-3
Lo YL, Huang JD (1999) In Vivo 13:51–55
Leu BL, Huang JD (1995) Cancer Chemother Pharmacol 35:6–432
Xiao YY, Ping QN, Chen ZP (2007) Int J Pharm 337:74–79. doi:10.1016/j.ijpharm.2006.12.034
Li Xi, Shen Qi (2008) Chromatographia 68:201–205. doi:10.1365/s10337-008-0713-4
Zhao K, Singh J (1998) J Control Release 55:253–260. doi:10.1016/S0168-3659(98)00053-4
Grass GM, Sweetana SA (1988) Pharm Res 5:372–376. doi:10.1023/A:1015911712079
Saitoh H, Aungst BJ (1995) Pharm Res 12:1304–1310. doi:10.1023/A:1016217505990
Shono Y, Nishihara H, Matsuda Y, Furukawa S, Okada N, Fujita T (2004) J Pharm Sci 93:877–885. doi:10.1002/jps.20017
Acknowledgments
The work was supported by the Shanghai Municiple Committee of Science and Technology (Grant No. 08DZ1971304), the National Basic Research Program of China (973 Program), No.2007CB936004, and the Key Projects of National New Drug 2009ZX09502-009.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, T., Shen, Q. & Pan, W. LC Determination of the Intestinal Absorption of Etoposide in Vitro and in Rat Plasma. Chroma 71, 993–998 (2010). https://doi.org/10.1365/s10337-010-1593-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-010-1593-y